Powered by

Hologic welcomes Dr Ludwig N. Hantson to board

Nov 20, 2018 - Global Banking News
Board and Executive Moves

Medical technology company Hologic Inc (Nasdaq:HOLX) disclosed on Monday the addition of Ludwig N. Hantson PhD to its board of directors with immediate effect.

Dr Hantson previously worked as president of Baxter BioScience as well as held leadership roles with Novartis AG and Johnson Johnson.

Most recently, Dr Hantson has served as president and chief executive officer of Baxalta Incorporated.

Currently, Dr Hantson serves as the chief executive officer of Alexion Pharma...